Speakers
KEYNOTE SPEAKERS
Professor of Chemical Pathology; Li Ka Shing Professor of Medicine,The Chinese University of Hong Kong, HONG KONG, SAR, CHINA.
Professor Dennis Lo is the Li Ka Shing Professor of Medicine and the Professor of Chemical Pathology of The Chinese University of Hong Kong (CUHK). He is also the Director of the Li Ka Shing Institute of Health Sciences at CUHK. He received his Bachelor of Arts degree from the University of Cambridge, and the Doctor of Medicine and Doctor of Philosophy degrees from the University of Oxford. He discovered the presence of cell-free fetal DNA in maternal plasma in 1997. Since then, he has been exploring the biology and diagnostic applications of plasma nucleic acids, realising a number of new tests for prenatal diagnosis and cancer testing. He has received a number of awards for his work, including a State Natural Science Award from the State Council of China in 2005 and the 2006 IFCC-Abbott Award for Outstanding Contribution to Molecular Diagnostics.
more...
Visiting Professor in Clinical Biochemistry, University of Oxford, Oxford, UK.
Dr. Christopher Price is Visiting Professor in Clinical Biochemistry at the University of Oxford and works as an independent consultant. Prior to this he was the Vice President of Outcomes Research for the Diagnostics Division of Bayer HealthCare, and before that he was Professor of Clinical Biochemistry at the London Hospital (later to merge with St. Bartholomew's) Medical School. He was also the Head of Clinical Biochemistry and the Director of Pathology at the associated teaching hospital. He is a Fellow of the Royal College of Pathologists, the Royal Society of Chemistry and the National Academy of Clinical Biochemistry. Dr. Price has been both Chairman and President of the Association for Clinical Biochemistry in the UK, as well as chair of the Association's Education Committee. He has been on the Board of Directors of AACC, as well as on the Organising Committees of the Oak Ridge Conference, the 2005 AACC Annual Meeting in Los Angeles, the Nominations Committee, and he is currently a member of AACC's Evidence-Based Medicine Committee.
Supporting Partners of the David Rothfield Memorial Oration:
Associate Professor, Faculty of Health Sciences, School of Biomedical Sciences, Curtin University of Technology, Perth, WA.
Associate Professor Williams graduated from Curtin University of Technology in 1974 with a double major in Histopathology and Medical Microbiology. His first appointment was in the Anatomical Pathology Department of the combined Sir Charles Gairdner Hospital and University of Western Australia Pathology service (HUPS). His interest in Diagnostic Cytology began in 1976 when he was appointed to the newly established HUPS cytology service and he progressed in this area to gain professional qualifications. He pursued further experience and accepted senior appointments managing the Histopathology and Cytology laboratories at Hollywood Repatriation General Hospital and later the St John of God Pathology Service before returning to his initial laboratory as Scientist in Charge of the Cytology unit in PathWest. He specialised in this area for the next 24 years and during this time obtained his Doctorate from the University of Western Australia (UWA) by research in the investigation of asbestos related lung diseases. In 2003 he accepted the Chief Scientist (Cytology) appointment at Western Diagnostic Pathology. During his career he has been involved in the education of scientists at a tertiary level and within the activities of the Australian Society of Cytology (ASC). His interest in education resulted in his appointment in 2008 to Curtin University as Associate Professor in the school of Biomedical Sciences where he is teaching Histopathology and Cytology.
He has been a career long member of AIMS and achieved Fellowship member ship in 1987. He has also been a member of the ASC since 1980 and has participated on local and National management committees and Boards of Education in a variety of roles during that time.
President-Elect, American Association for Clinical Chemistry (AACC)
Professor, Department of Pathology and Laboratory Medicine, University of North Carolina, USA
Professor Hammett-Stabler holds a BA in chemistry from Rollins College, a master’s degree in medical sciences/clinical chemistry from the University of Florida and a PhD in experimental pathology from the University of Alabama-Birmingham. She is a professor of Pathology and Laboratory Medicine at the University of North Carolina where her responsibilities focus on the service and educational missions of the university: she is the director of the McLendon Clinical Laboratories Core Laboratory and teaches a variety of students including clinical laboratory science undergraduates, graduate, dental and medical students, residents, and fellows. She also serves as the director of the ComACC accredited postdoctoral program.
She joined the AACC while a graduate student at UF and has since served on numerous AACC committees including the Personalised Medicine Advisory Group, Divisions Management Group, several Annual Meeting Organizing Committees, the Nominating Committee, the TDM/TOX Laboratory Improvement Program committee, and the editorial board of Clinical Chemistry News. She was drawn to the Therapeutic Drug Management and Toxicology Division because of her interest in those areas and has been very active in the division, serving as newsletter editor, member-at-large, secretary, and chair.
Within the National Academy of Clinical Biochemistry, Dr. Hammett-Stabler has participated in the preparation of Laboratory Medicine Practice Guidelines, served as chair of the Education and Scientific Affairs Committee, as secretary, and president. She holds membership in several additional professional and scientific organizations including IATDMCT, Sigma Xi, and AAAS. She actively supports certification through her involvement with the National Registry of Certified Chemists and the American Board of Clinical Chemistry. She has authored or co-authored over 100 papers, abstracts, and chapters related to clinical chemistry and laboratory medicine, and is an associate editor of Clinical Biochemistry.
Chair Division of Clinical Biochemistry & Immunology, Departmental Vice-Chair Information Management & Supply-Chain, Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Professor Grebe is currently the Chair of the Division of Clinical Biochemistry and Immunology and the departmental Vice-chair for Information Management in the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, positions he has held since 2006. He has been Consultant/Co-director of the Endocrine Laboratory and Automated Immunoassay Laboratory, of the same Department since 2002, as well as being an Associate Professor of Laboratory Medicine at the Mayo Clinic College of Medicine.
He was educated at Johann-Wolfgang-Goethe University, Frankfurt, Germany and carried out his medical doctorate by thesis at Justus-Liebig-University, Giessen, Germany before training in Internal Medicine and Endocrinology in Frankfurt and Wellington, followed by a stint as visiting Research Fellow at the Mayo Clinic and several years as a Senior Lecturer in Molecular Pathology at the Wellington School of Medicine and Health Sciences, before returning to Mayo in 2002.
Professor Grebe became a Fellow of the RACP in 1994 and gained DABCC certification in Clinical Chemistry (2006) and Molecular Diagnostics (2007) from the American Board of Clinical Chemistry.
Professor Grebe has been honoured with the Knoll Clinical Fellowship Award for Outstanding Thyroid Research - American Endocrine Society in 1996 and a Career Development Award - Royal Australasian College of Physicians and Supreme Royal Arch Chapter of New Zealand in 2000.
He has many presentations and publications to his name, plus several pending patent applications. Professor Grebe has a wide variety of research interests, including super sensitive TSH assays, thyroid disease (especially thyroid cancer), tumour genetic changes in thyroid carcinoma and conventional and molecular thyroid cancer tumour markers. Additional areas of interest include other endocrine malignancies, inherited endocrine tumour syndromes, and last, but not least, the application of mass-spectrometry in the clinical laboratory, in particular high-throughput applications and extension of clinical mass-spectrometry from steroid targets to peptides and proteins.
Other past and current activities include:
* Medical School Curriculum development.
* Development of many molecular genetic tests in both Wellington and at Mayo, ranging from infectious disease tests over conventional genetic tests for inherited diseases to molecular markers of minimal residual disease in tumour follow-up.
* Development of various several in-house immunoassay's at Mayo.
* Development and validation (in collaboration with vendors) of new automated immunoassay's.
* Co-development of several mass spectrometry assays at Mayo for steroids, biogenic amines and peptide hormones. Development of molecular-based hormone bio assays.
* Oversight of Information Management for the Department of Laboratory Medicine & Pathology.
President, Trillium Diagnostics, Brewer, Maine, USA.
Founder and President of Trillium Diagnostics, Dr Davis is a Hematopathologist, who received his education at Cornell University (B.S.) and University of Connecticut (M.D.). He started his academic career at Upstate-SUNY Medical Center in Syracuse, NY where he developed his interest in flow cytometry as a diagnostic tool in medicine. He then moved to Dartmouth-Hitchcock Medical Center, where he published extensively on reticulocyte analysis by flow cytometry and developed the diagnostic concept of the immature reticulocyte fraction, which is now a standard diagnostic parameter in anemia assessment in laboratory hematology. His research at Dartmouth also included the diagnostic utility of neutrophil CD64 for infection and sepsis. Dr. Davis co-founded with the late Dr. Berend Houwen from Groningen. NL the International Society for Laboratory Hematology and the journal Laboratory Hematology. Dr. Davis was Director of Flow Cytometry at William Beaumont Hospital in Michigan during 1994 – 2000; there he developed the first FDA-cleared method for fetomaternal hemorrhage detection using a flow cytometric technique with anti-HbF monoclonal antibodies. He has been active in numerous professional organizations and societies, having served as President for the Clinical Cytometry Society, Treasurer and Board member for the International Society for Laboratory Hematology, member of the Hematology Resource Committee for the College of American Pathologists, Treasurer for the International Committee for the Standardization of Haematology, and Chair of the area committee on hematology for CLSI (formerly NCCLS). He has over 100 peer-reviewed publications and serves on the editorial boards for journals of cytometry and laboratory hematology and has provided consultation to a number of medical diagnostic companies. Dr. Davis returned to his native New England at the turn of the century to establish Trillium Diagnostic, LLC, from which he continues his consulting activities, research and development of new diagnostic products for laboratory hematology, and works to establish acceptance of Leuko64 as a superior diagnostic assay for the detection of infection and sepsis.
more...
Clinical Professor, University of Western Australia
A medical pioneer whose work transcends all boundaries
In 2005 Barry J. Marshall and J. Robin Warren were awarded the Nobel Prize for Physiology or Medicine in recognition of their 1982 discovery that a bacterium, Helicobacter pylori, causes one of the most common and important diseases of mankind, peptic ulcer disease.
Barry Marshall met Robin Warren, a pathologist interested in gastritis, during internal medicine fellowship training at Royal Perth Hospital in 1981. The pair studied the presence of spiral bacteria in association with gastritis. The following year (1982), Helicobacter pylori was cultured for the first time and they developed their hypothesis related to the bacterial cause of peptic ulcer and gastric cancer.
In 1984, while at Fremantle Hospital, Marshall proved that the new germ was harmful in a well-publicised self-administered experiment, in which he drank a culture of H.pylori. Persevering despite widespread skepticism, Marshall also came up with combinations of drugs that killed the H.pylori bacteria and eliminated ulcers permanently.
The hypothesis that H.pylori is a causative factor of stomach cancer was accepted in 1994 by the World Health Organisation. This work has now been acknowledged as the most significant discovery in the history of gastroenterology and is compared to the development of the polio vaccine and the eradication of smallpox.
Affecting 50% of the global population, H.pylori is recognized as the most common chronic infection in the world. “Like a trail of crumbs, the DNA of our Helicobacter pylori can show where we were born and where our ancestors traveled from over the past 60,000 years” says Marshall.
In 2008 Professor Marshall was elected into the prestigious US National Academy of Science, an institution that was established in 1863 by President Abraham Lincoln. This recognition further establishes Barry’s international scientific credentials.
Barry was born in Kalgoorlie in 1951 and attended Marist Brothers College in Perth from 1960-68. He completed his undergraduate medical degree at The University of Western Australia in 1974.
Barry Marshall is married with four children and four grandchildren and lives in Subiaco, Western Australia.
Current Positions
Elected as a Foreign Member to the National Academy of Sciences
Clinical Professor of Medicine (University of Western Australia)
Consultant Gastroenterologist (Sir Charles Gairdner Hospital)
co-Director of the Marshall Centre for Infectious Diseases Research & Training
Founder and Director of ONDEK, a biotechnology company
Founder and Director of TRI-MED a diagnostics company
Ambassador for Life Sciences for Western Australia – a State Government appointment.
Honorary Patron of Scitech
Patron of the Monash Centre for Synchrotron Science
Francis R & Helen M. Pentz Professor of Science at Penn State University, USA
Guest Professor of Internal Medicine at Keio University, Japan
Recent Awards
Honorary Professor at the Third Military Medical University, Chongqing, China
Honorary Degree of Doctor of Science, honoris causea, University of Oxford, UK 2009
Honorary Doctorate in Medicine at Örebro University, Sweden 2009
Lennon K. Black Prize for Excellence in Biomedical Research, Jefferson College, USA 2008
The Keio Medical Science Prize 2002
Prince Mahidol Award for Public Health 2001
Fellow of the Australian Academy of Science 1999
Benjamin Franklin Medal for Life Science 1999
Member of the Royal Society, UK 1999
The Dr A.H. Heineken Prize for Medicine 1998
The Florey Medal, Australia 1998
The Gairdner Award, Toronto Canada 1996
The John Scott Award, City Of Philadelphia 1995
The Albert Lasker Award 1995
In conjunction with Dr Robin Warren
Nobel Prize for Physiology or Medicine 2005
Western Australian Citizen of the Year 2006
Western Australian of the Year 2007
The Companion in the General Division of the Order of Australia (AC) in 2007.
The Paul Ehrlich Prize 1997
Warren Alpert Prize 1995
INVITED SPEAKERS
| A/Prof Leon Adams Ms Susane Arentz Dr David Armbruster Mr Ian Arthur Ms Susan Badman Dr Tony Badrick Dr Ross Baker Ms Kathy Bayley Dr Jacky Bentel Ms Roslyn Bonar Ms Lyn Boscato Ms Imedla Bromilow Mr David Bryce Dr Alanah Buck Ms Wendy Carter Dr Paul Caterina Dr Adrian Charles Miss Angela Chiriano Ms Noelle Chow Dr Bridget Cooke Mr Geoff Coombs C/Prof Keryn Christiansen Ms Maxine Crook Mr Ruben David Prof Tim Davis Dr Bastiaan de Boer Ms Robyn Devenish Ms Tracy Dixon Mr John Dore Ms Gail Earl Dr Glenn Edwards Prof Leon Flicker Dr Chris Florkowski Prof Martyn French A/Prof Seng Khee Gan Dr Ian Gardner Dr Andrew Georgiou Ms Janice Gill |
Dr Paul Glendenning Mr Barry Gormley Ms Joanna Gray Dr Ronda Greaves A/Prof Ralph Green A/Prof David Groth Dr Narelle Hadlow Ms Ros Hackshaw Ms Elizabeth Haremza Mr Frank Haverkot A/Prof Marek Havlat Ms Naomi Heal Dr Richard Herrmann Mrs Kirsten Hoad Dr Geoff Isbister Mr Jeff Jago Dr Graham Jones Dr David Joske Mr Ian Kay Dr Ursula Kees Dr Stephen Knott Mr Gus Koerbin Prof Nigel Laing Ms Annette Le Viellez Dr Michael Legg Dr Nat Lenzo Dr Ee Mun Lim Mr Mark Mackay Dr Richard MacKay Ms Helen Martin Dr Jenny McCloskey Mr Bill McConnell Dr Andrew McQuillan Dr Michael Metz |
Dr Peter Mollee Prof Howard Morris Dr Delia Nelson Ms Lynn Nelson Ms Susan Neville Dr Victor J Ojeda Ms Lisa Oliffe Prof John Olynyk Mr Martyn Peck Ms Penny Petinos Ms Sally Pfeffer Mr Michael Platten Prof Thomas Riley Ms Heather Robins Dr Robyn Rodwell Ms Giuliana Romeo Ms Jennifer Ross W/Prof Christobel Saunders Ms Sue Scott A/Prof Mark Shephard Mr David Smith Dr Dominic Spagnolo Dr David Speers Prof Sergio Starkstein Dr Bronwyn Stuckey Dr Marian Sturm Mr Jim Thom Mr Robert Vanhaeften Dr Sam Vasikaran Ms Michaela Walters Dr Justin Waring Ms Robyn Wells Ms Loretta Wheatland Mr Geoff Whittaker Dr Cameron Willis Dr Campbell Witt Dr Nik Zeps |
© 2009